Symbols

Symbols

Aime

Products

News

Markets

Watchlist

Brokers

News/

Stock/

OKUR

OKUR News

Newswire

19:48

OnKure Therapeutics CFO and CEO Sell Shares Amid Ongoing Trading

09:14

ETFs With Most Upside to Analyst Targets: VTI, OnKure Therapeutics, FAT Brands, Metagenomi

10:49

HC Wainwright Raises OnKure PT to $34, Reiterates Buy Rating

07:19

OnKure Therapeutics: A Risky Investment Due to High Cash Burn

16:43

OnKure reports Q2 results, PIKture-01 trial on track for Q4 data, cash runway into Q4 2026.

View More

About OKUR

Charts

--

Sector--

Established Date--

Listing Date--

Exchange--

Full-time Employees--

Fiscal Year Ends--

Website

Security Type--

Office address

Business

Introduction

View More